Literature DB >> 10197666

Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage.

K B Allen1, L P Faber, W H Warren, C J Shaar.   

Abstract

BACKGROUND: Optimal management of cardiac tamponade resulting from pericardial effusion remains controversial.
METHODS: Cardiac tamponade in 117 patients was treated with either subxiphoid pericardiostomy (n = 94) or percutaneous catheter drainage (n = 23). Percutaneous catheter drainage was used for patients with hemodynamic instability that precluded subxiphoid pericardiostomy. Effusions were malignant in 75 (64%) of 117 patients and benign in 42 (36%) of 117.
RESULTS: Subxiphoid pericardiostomy had no operative deaths and a complication rate of 1.1% (1 of 94). In contrast, percutaneous drainage had significantly (p < 0.05) higher mortality and complication rates of 4% (1 of 23) and 17% (4 of 23), respectively. Patients with an underlying malignancy had a median survival of 2.2 months, with a 1-year actuarial survival rate of 13.8%. In comparison, patients with benign disease had a median survival of 42.8 months and a 1-, 2-, and 4-year actuarial survival rate of 79%, 73%, and 49%, respectively (p < 0.05). Effusions recurred in 1 (1.1%) of 94 patients after subxiphoid pericardiostomy compared with 7 (30.4%) of 23 patients with percutaneous drainage (p < 0.0001).
CONCLUSIONS: Benign and malignant pericardial tamponade can be safely and effectively managed with subxiphoid pericardiostomy. Percutaneous catheter drainage should be reserved for patients with hemodynamic instability.

Entities:  

Mesh:

Year:  1999        PMID: 10197666     DOI: 10.1016/s0003-4975(98)01192-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  28 in total

1.  Occult cardiac lymphoma presenting with cardiac tamponade.

Authors:  Douglas B Wilhite; Robert L Quigley
Journal:  Tex Heart Inst J       Date:  2003

2.  Pericardial decompression syndrome in a patient with hypothyroidism presenting as massive pericardial effusion: a case report and review of related literature.

Authors:  Aveline Sue Ann Lim Lim; Elizabeth Paz-Pacheco; Michael Reyes; Felix Punzalan
Journal:  BMJ Case Rep       Date:  2011-10-04

3.  Blind subxiphoid pericardiotomy to relieve critical acute hemopericardium: a final report.

Authors:  Y Kurimoto; K Maekawa; K Tanno; K Mori; T Koyanagi; T Ito; N Kawaharada; A Watanabe; T Higami; Y Asai
Journal:  Eur J Trauma Emerg Surg       Date:  2012-06-21       Impact factor: 3.693

4.  CT directed diagnostic and therapeutic pericardiocentesis: 8-year experience at a single institution.

Authors:  S V Klein; H Afridi; D Agarwal; B F Coughlin; L H Schielke
Journal:  Emerg Radiol       Date:  2005-07-16

Review 5.  Modern approaches and use of surgical treatment for pericardial disease.

Authors:  Edward P Chen; Joseph I Miller
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

6.  Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison.

Authors:  C Labbé; L Tremblay; Y Lacasse
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

7.  Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors:  Chiara Lestuzzi
Journal:  World J Cardiol       Date:  2010-09-26

8.  Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.

Authors:  Seyed Mohsen Mirhosseini; Mohammad Fakhri; Amirhossein Mozaffary; Mojtaba Lotfaliany; Neda Behzadnia; Zahra Ansari Aval; Seyed Mohammad Saeed Ghiasi; Mohammad Reza Boloursaz; Mohammad Reza Masjedi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-18

Review 9.  Identifying oncological emergencies.

Authors:  Achuta K Guddati; Nilay Kumar; Ankur Segon; Parijat S Joy; Creticus P Marak; Gagan Kumar
Journal:  Med Oncol       Date:  2013-07-20       Impact factor: 3.064

10.  Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients.

Authors:  Kan Yonemori; Hideo Kunitoh; Koji Tsuta; Tetsutaro Tamura; Yasuaki Arai; Yasuhiro Shimada; Yasuhiro Fujiwara; Yuko Sasajima; Hisao Asamura; Tomohide Tamura
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.